BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 17, 2000
View Archived Issues
NIH offers type I TNF receptor regulator for licensing
Read More
Wnt protein signaling found to control adipogenesis
Read More
Researchers discover protein required for protein translocation in bacteria
Read More
Licensing opportunity from NIH: gene amplification in cancer
Read More
NIH licensing opportunity: methods to inhibit cell motility
Read More
Atrix to use drug delivery technology to develop products for Pfizer
Read More
NIH licensing opportunity: system for functional identification of p53 mutations
Read More
NIH licensing opportunity: novel methods for MRA use in vessel delineation
Read More
CPMP recommends marketing approval for Serono's new treatment of female infertility
Read More
Viragen to file IND for Omniferon, enroll additional patients in HCV trial
Read More
Tularik initiates phase I study of anti-cytomegalovirus compound
Read More
Triangle Pharmaceuticals to proceed with Coactinon development
Read More
Novavax begins clinical trials of testosterone HRT
Read More
EpiCept to begin clinical development of cancer pain therapy
Read More
Zonagen receives SBIR grant to study SPRMs for endometriosis
Read More
GPC Biotech and Bayer establish antibacterial collaboration agreement
Read More
Swiss agency issues preapproval letter for Forcaltonin
Read More
Novartis on schedule for 2001 launch of Zelmac
Read More
Novel cell adhesion antagonists described
Read More
New compounds interacting with 5-HT4 receptor useful for gastrointestinal disorders
Read More
New series of tricyclic vasopressin agonists under study at AHP
Read More
New selective 5-HT3 antagonists useful as antiemetics
Read More
Novel AMPA antagonists under study at Kyorin
Read More
Novel antifungal agents under development at SS Pharmaceutical
Read More
